Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 28/10/2011
PIL Primovist 0.25 mmol/ml, solution for injection, prefilled syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
Updated on 23/07/2010 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Extra statutory information
Updated on 04/08/2009 and displayed until 23/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
  • Extra statutory information
Updated on 09/03/2009 and displayed until 04/08/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to MA holder contact details
Updated on 25/06/2008 and displayed until 09/03/2009
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Change of licence holder
  • Change to Marketing Authorisation Holder
Updated on 22/10/2007 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 18/09/2007 and displayed until 22/10/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 19/07/2007 and displayed until 18/09/2007
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 29/09/2006 and displayed until 19/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 18/05/2005 and displayed until 29/09/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   gadoxetic acid, disodium